Recent News and Updates
NEW – Intravenous Vitamin C – A Collaborative Article Between Oncologists and Naturopathic Physicians Working Together
New research on the practical use of Intravenous Vitamin C (IVC) in cancer from medical oncologists and naturopathic physicians working together which also includes discussions on how to use along with chemotherapy. The lower dosing guidelines as suggested in this article have been long supported in our clinical experiences as well.
Regional Hyperthermia Plus Chemotherapy Enhances Survival in Sarcoma Cancers
Recently a study published in JAMA Oncology demonstrated that the addition of regional hyperthermia to chemotherapy improved survival in patients with high-risk soft tissue sarcoma cancers.
Median local progression-free survival was 67.3 months in the hyperthermia group vs 29.2 months in the group without. Median disease-free survival was 33.3 months in the hyperthermia group vs 17.4 without. Median overall survival was 15.4 years with hyperthermia vs 6.2 years without, with 5-year survival rates of 62.7% vs 51.3% and 10-year survival rates of 52.6% vs 42.7%.
The use of hyperthermia or high temperature heating should be further explored in this area. Furthermore as the authors mention, “we should not exclude the potential therapeutic benefits regional hyperthermia may also have in solid tumors other than soft tissue sarcoma.”
We have noticed there are population groups where the addition of this technology appears to enhance not only chemotherapy, radiation, and even immunotherapy treatment approaches with several cancer types.
Please follow the below link to learn more about this interesting new article.
Mistletoe Intravenous in Cancer – much more than a Christmas decoration
The use of mistletoe in cancer is a popular treatment in cancer in many European countries. The common use is by injection given under the skin and there is a growing interest in the intravenous application. I would classify mistletoe as an original “immune-system” treatment that has finally become to the attention of the mainstream oncology community. Clinically we have seen patients with cancer respond to this form of treatment by improving quality of life symptoms such as in pain, appetite, and energy. Furthermore, there are groups where we have documented a cancer-fighting effect. The first patient we personally treated over 10 years ago was with advanced and progressing colon cancer, where the intravenous application of mistletoe stabilized his disease outside of any chemotherapy treatment. This experience opened our minds to the capabilities of this promising therapy.
The below recent study discusses the application and experience of mistletoe given by intravenous treatment to patients with cancer by a group of European physicians. Positive benefits were noted which included cases of patients whose disease was better controlled and more.
To find out more, please follow the below link.